Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,700
Closed -$372K 75
2025
Q2
$372K Buy
4,700
+200
+4% +$15.9K 0.81% 44
2025
Q1
$404K Buy
4,500
+100
+2% +$9.34K 1.06% 34
2024
Q4
$438K Buy
4,400
+2,000
+83% +$206K 0.97% 31
2024
Q3
$273K Buy
+2,400
New +$285K 0.58% 57

Other funds holding MRK

West Tower Group's MRK Position: Q3 2025 in Review

West Tower Group sold out of Merck (MRK) in Q3 2025, closing a stake of 4,700 shares — an estimated $372K sold.

West Tower Group first reported a position in MRK in Q3 2024 and held it in 4 quarters. The position peaked at $438K in Q4 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • West Tower Group reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • West Tower Group sold 4,700 Merck shares in Q3 2025, an estimated $372K.
  • West Tower Group first reported a position in Merck in Q3 2024 and held it in 4 quarters.
  • West Tower Group's Merck position peaked at $438K in Q4 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on West Tower Group's 13F filing for Q3 2025, filed 16 Oct 2025.